Background
==========

Idiopathic pulmonary fibrosis (IPF) is a devastating illness characterized by irreversible lung fibrosis \[[@b1-medscimonit-25-4285]\]. Although the overall prevalence of IPF is not high, the incidence of the disease has recently increased. In Europe and North America, the annual incidence of IPF is estimated to be between 2.8 and 18 cases per 100,000 individuals \[[@b2-medscimonit-25-4285]\]. The median age of IPF is about 65 years, and men have a higher incidence \[[@b3-medscimonit-25-4285],[@b4-medscimonit-25-4285]\]. Wound healing results in fibrosis and is believed to be the basis for the pathogenesis of IPF and includes the stages of homeostasis, inflammation, cell migration, cell proliferation, and extracellular matrix (ECM) remodeling. IPF may be due to chronic injury of the alveolar epithelium that results in pulmonary fibrosis and structural lung remodeling \[[@b5-medscimonit-25-4285]\]. However, the etiology of IPF remains unknown.

Currently, IPF is considered to be a result of the interaction between genetic and environmental risk factors \[[@b6-medscimonit-25-4285]\], and aging might influence the susceptibility to lung fibrosis, as the incidence of IPF increases with age \[[@b7-medscimonit-25-4285]\]. Also, genome-wide association studies have shown that some genes related to host defense and epithelial barrier function may also be involved in the pathogenesis of IPF \[[@b8-medscimonit-25-4285]\]. Among these genes, a variant of the MUC5B promoter region was shown to be involved in the development of IPF \[[@b9-medscimonit-25-4285]\]. In terms of environmental factors, cigarette smoking has been proposed to be the most common association with IPF \[[@b10-medscimonit-25-4285]\]. Other inhaled environmental agents include exposure to metal dust or wood dust, sand, and spores from soil \[[@b4-medscimonit-25-4285],[@b11-medscimonit-25-4285]\]. IPF remains a challenging disease to treat, and further studies are needed to improve the understanding of the underlying molecular mechanisms to identify gene targets for the development of novel therapies.

There are a large number of microarray gene expression datasets that are publicly available from the Gene Expression Omnibus (GEO) database. There is an increasing demand to integrate gene expression datasets to obtain more accurate results \[[@b12-medscimonit-25-4285]\]. There have been no previous studies that have undertaken comprehensive bioinformatics analysis in IPF. Therefore, this study aimed to perform a comprehensive analysis approach by using a robust rank aggregation (RRA) method to identify the differentially expressed genes (DEGs) from several datasets \[[@b13-medscimonit-25-4285]\]. The connectivity map (CMAP) (*<https://portals.broadinstitute.org/cmap/>*) transcriptional expression database was chosen to identify gene-expression signatures associated with IPF, as CMAP represents a valuable tool for establishing the connections between genes, drugs, and diseases and contains over 7000 gene expression profiles reflecting 1309 bioactive compounds \[[@b14-medscimonit-25-4285]\]. CMAP can be used to identify mechanisms of action of small molecules and identify novel therapeutic targets \[[@b15-medscimonit-25-4285]\]. The signature of differentially expressed genes (DEGs) can be used to input into the CMAP. Also, weighted gene coexpression network analysis (WGCNA) is a powerful approach for exploring the complex relationships between gene expression profiles and phenotype \[[@b16-medscimonit-25-4285]\]. Therefore, in the present study, WGCNA was used to build a gene coexpression network and screen important modules in the network, and to filter the hub genes in the essential modules.

Therefore, this study aimed to identify key genes and significant signaling pathways involved in IPF using bioinformatics analysis. DEGs from lung tissue microarray data were identified from patients with IPF and normal controls, and potential gene targets for the treatment of IPF were detected using the CMAP database. WGCNA was used to construct a coexpression network associated with IPF to identify significant modules and hub genes, that may be related to the pathogenesis of IPF.

Material and Methods
====================

Datasets used
-------------

The gene expression datasets from idiopathic pulmonary fibrosis (IPF) were downloaded from the Gene Expression Omnibus (GEO) repository (*<http://www.ncbi.nlm.nih.gov/geo/>*). The GEO represents the largest resource of public microarray data and is widely used to identify key genes in disease. In this study, there were several selection criteria for data selection that included: (a) gene expression datasets which contained gene chip microarrays; (b) studies comparing gene expressions between patients with IPF and normal control lung tissue; (c) sample size in each chip dataset contained at least ten samples; (d) raw data or processed data were available in these databases; (e) hypersensitive pneumonitis, cryptogenic organizing pneumonia (COP), or respiratory bronchiolitis-interstitial lung disease (RBILD) were not included in this study. Searches were excluded if they did not meet the inclusion criteria.

All patients with IPF included in this study met the diagnostic criteria for IPF based on the American Thoracic Society (ATS) and European Respiratory Society (ERS) consensus statement. Lung tissue samples from the normal control groups were obtained from patients without IPF and included lung cancer patients and lung transplant patients. Ethical approval for this study was not required because the data were downloaded directly from public datasets.

Integrated analysis of gene expression datasets
-----------------------------------------------

Microarray data preprocessing were executed using R Project software and Bioconductor packages \[[@b17-medscimonit-25-4285]\]. The raw microarray data were converted to expression data using the robust multi-array average (RMA) algorithm based on R language \[[@b18-medscimonit-25-4285]\]. Also, two preprocessed series matrix files were directly downloaded from the GEO repository. Probes were mapped to gene symbols. The average gene expression levels were calculated for genes represented by more than one probe. The differentially expressed genes (DEGs) between patients with IPF and normal controls in each dataset were screened by the Limma package in R \[[@b19-medscimonit-25-4285]\]. Integrated analysis for the DEGs obtained from the six eligible datasets was performed using the R package (Robust Rank Aggregation), based on a robust rank aggregation (RRA) method. Also, \|logFC\| ≥1 and P\<0.05 were used as the cutoff criteria for screening the DEGs.

Screening of small molecules
----------------------------

To identify candidate small molecules, we compared the DEGs with the 1,309 different compounds in the connectivity map (CMAP) used to identify gene-expression signatures associated with IPF. The DEGs were input to CMAP software for analysis, according to the website instructions. Small molecules with negative connectivity scores, representing the compounds that might reverse the input signature, were identified as therapeutic agents. The small molecules with average scores \<−0.3 and P\<0.05 were selected ([Table 1](#t1-medscimonit-25-4285){ref-type="table"}).

Weighted gene coexpression network analysis (WGCNA)
---------------------------------------------------

The WGCNA package was used to construct the coexpression network. GSE32537 which including 119 patients with IPF and 50 normal controls was analyzed by WGCNA. We calculated the coefficient of variation for each gene. The top 5,000 genes with the highest coefficient of variation were selected for further analysis by constructing a weighted gene coexpression network. The appropriate power value was determined when the independence degree was up to 0.9. The merge cut height of 0.3 and the minimal module size of 100 were explored to identify coexpression modules. The modules were randomly color-labeled. Genes that could not be clustered into any given module were assigned to the grey module. The coexpression networks were visualized by Cytoscape software version: 3.6.1 (*<http://www.cytoscape.org/>*) \[[@b20-medscimonit-25-4285]\]. We identified modules that were significantly associated with IPF by calculated the correlation between module eigengenes and clinical features. Finally, the modules that were highly correlated with clinical function were chosen for further analysis.

Identification and validation of hub genes in key modules
---------------------------------------------------------

Module membership (MM) represented the correlation of gene expression profile with the module eigengene. The top 30 genes with the highest connectivity in key modules were regarded as hub genes and were visualized with Cytoscape. The expression statuses of hub genes in key modules were identified for validation. Venn diagram was plotted using the online JVenn tool to overlap the hub genes in significant modules and DEGs obtained from the RRA analysis \[[@b21-medscimonit-25-4285]\].

Functional enrichment analysis
------------------------------

Genes in interest modules were uploaded to the online bioinformatics database Metascape (*<http://metascape.org/>*) and underwent Gene Ontology (GO) biological process, cellular component, and molecular function analysis as well as Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway enrichment analysis \[[@b22-medscimonit-25-4285]\]. The number of enriched genes ≥3 and P\<0.01 were regarded as the cutoff criteria. Only the top ten enriched pathways were extracted.

Results
=======

Microarray datasets for idiopathic pulmonary fibrosis (IPF)
-----------------------------------------------------------

After selection according to the eligibility criteria, six datasets were incorporated into the study: GSE10667 \[[@b23-medscimonit-25-4285]\], GSE15197 \[[@b24-medscimonit-25-4285]\], GSE21369 \[[@b25-medscimonit-25-4285]\], GSE24206 \[[@b26-medscimonit-25-4285]\], GSE32537 \[[@b27-medscimonit-25-4285]\], GSE110147 \[[@b28-medscimonit-25-4285]\] ([Table 2](#t2-medscimonit-25-4285){ref-type="table"}). The main characteristics of these publicly available databases including gender ratio, and age distribution, origin, number of samples, GSE number, platforms, and source types are listed in [Table 2](#t2-medscimonit-25-4285){ref-type="table"}. The number of patients with IPF ranged from 8 to 119, and the number of normal controls ranged from 6 to 50. In total, 191 patients with IPF and 101 normal controls were enrolled in the study.

Robust rank aggregation (RRA) analysis
--------------------------------------

By using the RRA approach to integrate six microarray datasets, a total of 368 differentially expressed genes (DEGs) comprising 248 upregulated and 120 downregulated genes were obtained ([Supplementary Table 1](#s1-medscimonit-25-4285){ref-type="supplementary-material"}). The top 25 upregulated and downregulated genes are shown in [Figure 1](#f1-medscimonit-25-4285){ref-type="fig"}. Among these DEGs, the roles of some genes in IPF have been validated in previous studies, including KRT5, BPIFB1, and AGER.

Screening for small molecules
-----------------------------

The connectivity map (CMAP) database was used to search for small molecules with therapeutic potential in IPF. The small molecules with a high negative connectivity score are presented in [Table 1](#t1-medscimonit-25-4285){ref-type="table"}. Among these potential therapeutic agents, pregnenolone and lycorine showed a smaller P-value and were potential therapeutic targets for IPF.

Weighted gene coexpression network analysis (WGCNA)
---------------------------------------------------

According to the order of the coefficient of variation, the 5,000 most variable genes were chosen for WGCNA. Hierarchical clustering analysis was performed, and the results are shown in [Supplementary Figure 1](#s3-medscimonit-25-4285){ref-type="supplementary-material"}. There were three outlier samples in the 169 samples that included GSM806290, GSM806408, GSM806411 when the threshold was set as 55. Outlier samples were removed from the cohort before further analysis. As shown in [Figure 2A](#f2-medscimonit-25-4285){ref-type="fig"}, power=5 was chosen as the soft-thresholding to ensure a scale-free network. We set the minimum module size to 100 genes and the minimum cut height for merging of modules at 0.3. The weighted gene coexpression network analysis (WGCNA) identified eight modules ranging in size from 228 to 1808.

There were 45 genes that did not belong to any module were labeled in grey, which were excluded from further analysis. These coexpression modules were constructed and were presented in different colors ([Figure 2B](#f2-medscimonit-25-4285){ref-type="fig"}). Interactions between the eight coexpression modules were then analyzed ([Figure 2C](#f2-medscimonit-25-4285){ref-type="fig"}). To explore the clinical significance of the module, correlations between module eigengenes and clinic traits were analyzed. As shown in [Figure 3](#f3-medscimonit-25-4285){ref-type="fig"}, black, blue, magenta, and pink modules were positively correlated with two clinical traits, namely disease status and the St George's score for the severity of IPF. By contrast, yellow, brown, and red modules were found to be negatively associated with disease status and St George's score for severity of IPF.

Also, we found some positive correlations between the black module and smoking pack years. Combined with [Figure 4](#f4-medscimonit-25-4285){ref-type="fig"}, we observed that these seven modules yielded two main clusters; one included four modules (black, blue, magenta and pink module) while the other included three modules (yellow, brown and red). Furthermore, two pairs of modules had higher adjacencies, and they were the black and magenta module, yellow and brown module respectively. Also, the module eigengene of the black and yellow module showed a higher correlation with disease status ([Figure 3](#f3-medscimonit-25-4285){ref-type="fig"}). The black module had the strongest positive correlation with IPF (r=0.79; P=4e--37) while the yellow module had the strongest negative correlation with IPF (r=−0.81; P=3e--40). We plot a scatterplot for the correlation between module membership and gene significance in the two key modules, respectively ([Figure 5](#f5-medscimonit-25-4285){ref-type="fig"}). The coexpression networks were visualized with Cytoscape and are shown in [Supplementary Figure 2](#s4-medscimonit-25-4285){ref-type="supplementary-material"}.

Identification and validation of hub genes in the key modules
-------------------------------------------------------------

Hub genes may determine the characteristics of a module and play significant roles in biological processes. Consequently, the top 30 genes with the highest degree of connectivity in the black and yellow module were taken as hub genes, including COL14A1, TSHZ2, IL1R2, and SLCO4A1. [Figure 6A and 6B](#f6-medscimonit-25-4285){ref-type="fig"} showed the top 30 hub genes in the black and yellow module. We used DEGs generated from RRA analysis to validate the expression status of the top two hub genes in the black and yellow module. We overlapped the DEGs and genes in the black and yellow module by plotting a Venn diagram. These four hub genes were present in DEGs and significant modules, indicating their value as potential biomarkers for IPF. The results are presented in [Figure 7](#f7-medscimonit-25-4285){ref-type="fig"}.

Functional enrichment analysis
------------------------------

Functional enrichment analysis was performed for the genes in the constructed seven modules. The genes in the black module were mainly enriched in extracellular matrix (ECM) organization, skeletal development, and vasculature development ([Figure 8A](#f8-medscimonit-25-4285){ref-type="fig"}). Genes in the yellow module were enriched in myeloid leukocyte migration, leukocyte activation, and were involved in the immune response and the inflammatory response ([Figure 8B](#f8-medscimonit-25-4285){ref-type="fig"}). Genes in the brown module were mainly enriched in blood vessel development, cell junction organization, and sterol biosynthetic. Genes in the blue module were mainly involved in cilia, motile cilia, and O-glycan processing. Multiple signaling pathways were found to be involved in other modules, including nuclear division in the magenta module, T cell activation in the pink module, and olfactory transduction in the red module. The main results in Gene Ontology (GO) biological process, cellular component, and molecular function analysis and the Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway enrichment analysis of these seven modules are shown in [Supplementary Table 2](#s2-medscimonit-25-4285){ref-type="supplementary-material"}.

Discussion
==========

Idiopathic pulmonary fibrosis (IPF) is a progressive and devastating disease that usually leads to death within five years after diagnosis \[[@b29-medscimonit-25-4285]\]. The pathogenesis of the disease remains poorly understood. In the current study, we conducted an integrated analysis of gene expression data to explore the molecular pathogenesis of IPF. In this study, the robust rank aggregation (RRA) method, was used to screen significant differentially expressed genes (DEGs) from six independent gene expression datasets. A large number of DEGs were identified from which 248 DEGs were upregulated and 120 DEGs were down-regulated in IPF patient samples compared with control samples.

IPF is the result of chronic inflammation and healing in the lung. This study identified some DEGs that were closely associated with inflammation and healing. It was previously reported that KRT5 was highly expressed in the alveolar regions of the lung in IPF \[[@b30-medscimonit-25-4285]\]. Also, airway stem cells have been shown to express KRT5 in lung injury \[[@b31-medscimonit-25-4285]\]. The findings from these previous studies support that KRT5 is associated with the process of healing in the alveolar epithelium. BPIFB1 has also been previously shown to be upregulated in respiratory disease, including in chronic obstructive pulmonary disease (COPD) where it has been associated with disease severity \[[@b32-medscimonit-25-4285]\]. Also, an ulcer-associated cell lineage plays an important role in the healing process in inflammatory bowel disease, and BPIFB1 is one of the ulcer-associated cell lineage genes \[[@b33-medscimonit-25-4285]\]. Therefore, it is possible that BPIFB1 plays a significant role in the healing process in IPF.

PLA2G1B, a secreted phospholipase, was among the most downregulated genes in IPF in the present study. There have been few previous studies on PLA2G1B in IPF, and so the aberrant expression of this gene should be validated by future studies. AGER, or advanced glycosylation end product-specific receptor, is one of the DEGs that were significantly down-regulated in the present study. Advanced glycosylation end product (AGE) has been previously shown to inhibit the wound-healing in diabetes by reducing the activity of epidermal stem cells \[[@b34-medscimonit-25-4285]\]. However, blocking the expression of AGER may facilitate the healing process, which may explain the possible role for AEGR in IPF.

Some candidate molecules with therapeutic potential in IPF were explored based on the use of the connectivity map (CMAP) database to identify gene expression signatures. Pregnenolone is an inactive precursor of steroid hormones, and its potential functional effects have been previously studied \[[@b35-medscimonit-25-4285]\]. Pregnenolone therapy has shown beneficial effects in schizophrenia \[[@b36-medscimonit-25-4285]\], bipolar depression \[[@b37-medscimonit-25-4285]\], and drug dependence \[[@b38-medscimonit-25-4285]\]. Prospective studies are needed to investigate pregnenolone as a candidate therapeutic compound in IPF. Lycorine is an alkaloid derived from *Hymenocallis littoralis*, which has antibacterial, antiviral, and wound-healing properties \[[@b39-medscimonit-25-4285]\]. The findings from a previous study suggested that lycorine might have therapeutic potential in patients with IPF \[[@b40-medscimonit-25-4285]\]. This previous finding was consistent with the findings from the present study, and lycorine is a molecule that requires further study.

The method of WGCNA that was the basis of this study is an efficient approach to construct coexpressed modules and hub genes in several diseases \[[@b41-medscimonit-25-4285]\]. In this study, we investigated the gene expression profile of GSE32537, including 119 patients with IPF and 50 normal controls to explore the molecular mechanism of IPF. Using WGCNA, the weighted coexpression network was constructed, and eight coexpression modules were identified. Seven of the modules showed a significant correlation with disease status, which were divided into two clusters, providing new insights into the pathogenesis of IPF. Among the identified modules, the black, blue, magenta, and pink modules were positively associated with disease status, whereas the yellow, brown, and red modules were negatively correlated with disease status. To determine the importance of these coexpression modules in the pathogenesis of IPF, enrichment analysis was performed using the Metascape online bioinformatics gene annotation and analysis database. The black module was found to be mainly enriched in collagen-containing extracellular matrix (ECM) and the ECM component. Increased accumulation of ECM is an important phase of the wound-healing process. ECM has been identified as an active contributor to the progression of fibrosis \[[@b42-medscimonit-25-4285]\]. A therapeutic approach that targets the ECM may reverse fibrosis and restore lung function. The results of this study showed that the yellow module was mainly enriched in myeloid leukocyte migration and leukocyte activation involved in the immune response, and in cell migration. These results were consistent with previous studies that immune signaling pathways may be protective in IPF \[[@b43-medscimonit-25-4285]\].

The black and yellow modules were found to be most significantly correlated with the disease status of IPF. Therefore, we screened the hub genes and validated the top two hub genes in the two modules. These four hub genes were all present in DEGs and significant modules, indicating their important roles in biological processes. COL14A1 is a member of the fibril-associated collagens with interrupted triple helices (FACIT) collagen family, with the main function of collagen binding and ECM components \[[@b44-medscimonit-25-4285]\]. COL14A1 expression has been reported to be significantly upregulated in the pulmonary artery intima and media of patients with pulmonary arterial hypertension \[[@b45-medscimonit-25-4285]\]. It is likely that COL14A1 plays a key role in the process of pulmonary interstitial fibrosis.

In this study, TSHZ2, a zinc-finger homeobox gene, was identified as a hub gene. Studies on the role of TSHZ2 are limited, and future studies are required to confirm its function in IPF. IL1R2 is a member of the interleukin-1 receptor family and acts as a negative regulator of the IL-1 system. The anti-inflammatory effect of IL1R2 has been confirmed by *in vivo* studies, and include chronic skin inflammation \[[@b46-medscimonit-25-4285]\], and arthritis \[[@b47-medscimonit-25-4285]\]. The combination of acute inflammation and healing due to persistent injury results in fibrosis \[[@b48-medscimonit-25-4285]\]. In the present study, IL1R2 was both a hub gene and a significantly down-regulated gene in the IPF group, suggesting that the overactive wound healing was most likely associated with the functional deletion of IL1R2. SLCO4A1 is a member of solute carrier organic anion transporter family, which is involved in the transport of a variety of compounds \[[@b49-medscimonit-25-4285]\]. There have been few studies on SLCO4A. However, SLCO4A1 has been shown to have a role in the proliferation of colorectal cancer cell and cell migration *in vitro* and to be a negative prognostic marker *in vivo* \[[@b50-medscimonit-25-4285]\]. Further studies are required to determine the role of SLCO4A1 in IPF.

The key genes identified in this study were associated with the pathogenesis of fibrosis, including in IPF, and the findings were supported by those from previously published studies. However, this study had several limitations. Only six datasets of microarray data for IPF were used. Few clinical and regional characteristics of the patients were available in each dataset, and there may have been relevant clinical differences that affected the findings. Also, the results obtained by bioinformatics analysis alone should be verified by *in vitro* and clinical studies, and so further studies are needed to validate these preliminary findings.

Conclusions
===========

Through the comprehensive bioinformatics analysis of several gene expression datasets, we identified differentially expressed genes (DEGs) that might be related to the pathogenesis, diagnosis, and prognosis of idiopathic pulmonary fibrosis (IPF). Also, relevant small molecules were predicted using the connectivity map (CMAP) database to identify gene expression signatures associated with IPF, which might be potential candidate therapeutic compounds for IPF. We used weighted gene coexpression network analysis (WGCNA) to build a coexpression network associated with IPF and found two modules and four hub genes, which might identify novel insights into the molecular mechanisms underlying IPF. The findings of this study should be confirmed by future *in vitro* and clinical studies.

Supplementary Files
===================

###### 

Genes statistically differentially expressed between IPF and normal lung tissue.

  Name         Pvalue        adjPvalue     logFC
  ------------ ------------- ------------- --------------
  KRT5         8.16E-19      2.28E-14      2.935163698
  BPIFB1       1.66E-17      4.63E-13      2.816100513
  MMP1         1.71E-14      4.77E-10      2.975972266
  MMP7         1.34E-13      3.74E-09      2.778138388
  GPR87        7.23E-13      2.02E-08      2.297678786
  ZBBX         2.63E-12      7.32E-08      2.096953319
  COL3A1       3.10E-12      8.63E-08      1.951786774
  TMEM45A      3.76E-12      1.05E-07      1.713292282
  IL13RA2      5.28E-12      1.47E-07      2.127651882
  MSMB         5.52E-12      1.54E-07      2.086340891
  CXCL13       5.89E-12      1.64E-07      1.873998487
  CLCA2        7.28E-12      2.03E-07      1.753165017
  PROM1        9.11E-12      2.54E-07      2.236427095
  KRT15        9.44E-12      2.63E-07      2.084821277
  CHST9        2.38E-11      6.65E-07      1.946570653
  CP           3.27E-11      9.12E-07      2.161658822
  TMPRSS4      5.71E-11      1.59E-06      1.929477651
  SFRP2        1.05E-10      2.93E-06      2.29394319
  SPP1         1.97E-10      5.49E-06      2.416271247
  COL1A1       2.32E-10      6.48E-06      1.865800024
  CNTN3        2.83E-10      7.88E-06      1.42949464
  COL14A1      3.89E-10      1.09E-05      1.676170261
  CASC1        5.95E-10      1.66E-05      1.506540304
  DIO2         6.13E-10      1.71E-05      1.458989173
  ARMC3        6.62E-10      1.85E-05      1.864747862
  SULF1        8.52E-10      2.38E-05      1.407676411
  SERPINB3     8.76E-10      2.44E-05      1.822592533
  KLHL13       8.85E-10      2.47E-05      1.415638864
  CXCL14       9.30E-10      2.59E-05      1.831177737
  ASPN         9.62E-10      2.68E-05      1.840973138
  SERPINB5     9.62E-10      2.68E-05      1.120680021
  C20orf85     9.97E-10      2.78E-05      1.801814831
  SPAG17       1.04E-09      2.91E-05      1.646375125
  LRRC17       1.08E-09      3.02E-05      1.396901134
  SLC27A2      1.14E-09      3.19E-05      1.556826086
  POSTN        1.17E-09      3.27E-05      1.85302783
  SNTN         1.42E-09      3.97E-05      1.875956956
  KRT17        1.46E-09      4.07E-05      1.959920244
  CDH3         1.68E-09      4.68E-05      1.930510747
  FANK1        1.95E-09      5.43E-05      1.503991449
  MMP13        2.09E-09      5.84E-05      1.757375715
  CCDC146      2.34E-09      6.53E-05      1.492462573
  RSPH1        3.52E-09      9.82E-05      1.724507872
  FAM81B       3.76E-09      0.000104985   1.776467268
  VTCN1        4.32E-09      0.000120533   1.683907215
  COMP         5.67E-09      0.000158194   2.319702189
  RGS22        5.86E-09      0.000163421   1.446072149
  MUC16        6.35E-09      0.000177097   1.571239322
  SPATA18      6.42E-09      0.000179133   1.394998539
  TSHZ2        7.05E-09      0.000196678   1.118911148
  CAPSL        7.48E-09      0.000208696   1.638856212
  TTC25        7.63E-09      0.000212835   1.30957343
  COL1A2       8.27E-09      0.000230588   1.502829774
  SFRP4        9.37E-09      0.000261414   1.230284362
  DCLK1        9.88E-09      0.000275575   1.272063729
  CYP2F1       1.02E-08      0.000283711   1.223127058
  WDR78        1.22E-08      0.000338888   1.267174919
  PSD3         1.32E-08      0.000368616   1.140913494
  WDR63        1.49E-08      0.000414831   1.401986713
  LTBP1        1.58E-08      0.000439688   1.310736879
  CFH          1.60E-08      0.000447383   1.387921751
  COL6A3       1.67E-08      0.000466154   1.120968356
  NELL2        2.06E-08      0.000573796   1.111579211
  CCDC113      2.21E-08      0.000616382   1.272100841
  C6           2.50E-08      0.000696175   1.739230141
  ST6GALNAC1   3.03E-08      0.000843723   1.390920015
  RPS4Y1       3.22E-08      0.000898467   1.966604231
  SPAG6        3.51E-08      0.000979708   1.755246732
  TTC29        3.73E-08      0.001040815   1.400611802
  SCGB1A1      3.96E-08      0.001105576   1.472963895
  MMP10        4.06E-08      0.001132187   1.850435932
  SPATA17      4.39E-08      0.001225456   1.386846091
  SLN          4.48E-08      0.001248606   1.539423446
  S100A2       4.48E-08      0.001250099   2.029971633
  DSC3         4.53E-08      0.00126211    1.633315606
  TSPAN1       5.09E-08      0.001418504   1.501762841
  AGBL2        5.14E-08      0.001433455   1.265354573
  DYNLRB2      6.25E-08      0.001742309   1.426611109
  LTF          6.70E-08      0.00186864    1.362389488
  MYH11        6.96E-08      0.001941834   1.020881259
  SLITRK6      7.19E-08      0.00200411    1.524418276
  SLC4A11      7.32E-08      0.002041705   1.021480991
  LRRC46       7.46E-08      0.002081847   1.39939705
  LCN2         7.55E-08      0.00210533    1.519553185
  MDH1B        8.81E-08      0.002456185   1.238493664
  PTPRZ1       9.04E-08      0.00252096    1.027109023
  THBS2        9.08E-08      0.002531893   1.217132935
  KRT6A        9.20E-08      0.002564929   1.843710106
  FAT2         9.48E-08      0.002643413   1.436657195
  CCDC80       1.17E-07      0.003264358   1.287638765
  COL15A1      1.23E-07      0.003431577   1.558457712
  PRUNE2       1.24E-07      0.003458424   1.189978667
  AQP5         1.52E-07      0.004250384   1.059448724
  IGF1         1.56E-07      0.004358779   1.334563461
  LGALS7B      1.58E-07      0.004406939   1.303091197
  PTGFRN       1.67E-07      0.004670182   1.086813811
  GPX8         1.73E-07      0.004814652   1.169574353
  MNS1         2.05E-07      0.005724399   1.273932547
  KRT14        2.08E-07      0.005811711   1.243073844
  HSPA4L       2.14E-07      0.005980132   1.321865881
  FNDC1        2.18E-07      0.006074683   1.48019782
  GREM1        2.37E-07      0.006620838   1.465380281
  C9orf135     2.75E-07      0.007658837   1.41427499
  FBXO15       2.91E-07      0.008110255   1.068188235
  CAPS         3.02E-07      0.008414294   1.197249034
  THY1         3.02E-07      0.008436056   1.488425651
  SYNPO2       3.22E-07      0.008985261   1.113568786
  MUC5B        3.32E-07      0.009247558   1.197014038
  CDH2         3.98E-07      0.011111537   1.260162496
  STOML3       4.27E-07      0.011895241   1.499556832
  KRT6C        4.60E-07      0.012826127   1.589275459
  PLN          4.76E-07      0.013269168   1.064513896
  SERPINF1     5.56E-07      0.01550185    1.162722912
  DNAH12       5.83E-07      0.016251891   1.553317339
  LRRN1        5.89E-07      0.016415964   1.328297804
  TEKT1        6.01E-07      0.01675329    1.546529799
  C11orf88     6.13E-07      0.017103725   1.484628508
  COL5A2       6.29E-07      0.017538773   1.024345467
  EYA2         6.29E-07      0.017543232   1.183016083
  SERPINI2     6.29E-07      0.017543232   1.126653922
  MEOX1        6.39E-07      0.017834057   1.228643451
  CTHRC1       6.78E-07      0.018915173   1.529655688
  MUC4         6.92E-07      0.019312725   1.084574554
  MORN5        7.01E-07      0.01955195    1.494365253
  TNFRSF17     7.30E-07      0.020371412   1.013826148
  SCG5         7.31E-07      0.020381583   1.604114371
  SERPIND1     8.50E-07      0.023696112   1.380147985
  STK33        8.98E-07      0.025033914   1.255678765
  ENKUR        9.00E-07      0.025094148   1.441136955
  BCHE         9.00E-07      0.025094148   1.010033179
  NEK10        9.52E-07      0.026552979   1.447262547
  EFCAB1       9.74E-07      0.027176271   1.549417004
  LRRIQ1       9.93E-07      0.027688035   1.502569257
  ALDH3A1      1.03E-06      0.028723921   1.057312477
  UBXN10       1.05E-06      0.029384698   1.17634531
  GSTA1        1.08E-06      0.030063269   1.608489358
  CCL18        1.09E-06      0.03047741    1.027242614
  CTSE         1.25E-06      0.034820248   1.051893038
  COL10A1      1.37E-06      0.038142045   1.30970437
  CTSK         1.38E-06      0.038348612   1.094051078
  TRIM29       1.46E-06      0.040680309   1.110754893
  EFHC2        1.62E-06      0.04516481    1.129952453
  GOLM1        1.64E-06      0.045682808   1.068976108
  TEKT2        1.65E-06      0.045921326   1.358996882
  C11orf70     1.77E-06      0.049452252   1.162790469
  SOX2         1.89E-06      0.052746565   1.502511435
  AMPD1        2.03E-06      0.056590851   1.005313806
  CYP24A1      2.07E-06      0.057621316   1.284583408
  CD24         2.21E-06      0.061555849   1.261804161
  WDR66        2.23E-06      0.062226218   1.15117896
  ANKFN1       2.28E-06      0.063660615   1.001663679
  HS6ST2       2.46E-06      0.068471393   1.092390297
  EIF1AY       2.47E-06      0.068819733   1.084622032
  WDR49        2.80E-06      0.078202171   1.32678646
  C9orf24      2.82E-06      0.078602712   1.508651167
  DNAH9        2.95E-06      0.08233687    1.467446672
  CXCL6        3.02E-06      0.084225814   1.319295673
  CHST6        3.14E-06      0.087627154   1.358514328
  PIP          3.23E-06      0.090079114   1.372153545
  ABCA13       3.23E-06      0.090079114   1.326351733
  C6orf118     3.37E-06      0.093849633   1.41969099
  ARMC4        3.54E-06      0.09872715    1.222717911
  RPGRIP1L     3.83E-06      0.10687075    1.099001594
  KCNJ16       4.09E-06      0.113975886   1.083243034
  FAP          4.18E-06      0.116579023   1.019870168
  CCDC17       4.23E-06      0.117867727   1.156041743
  PIH1D2       4.25E-06      0.118602386   1.005323245
  C7orf57      4.56E-06      0.127210058   1.09585796
  FAM83D       4.87E-06      0.13594777    1.237173638
  EFHC1        4.93E-06      0.137528392   1.063614057
  EFHB         5.01E-06      0.139621819   1.053752603
  DNAI2        5.34E-06      0.148888408   1.179025366
  TMEM190      5.44E-06      0.151608905   1.351028578
  BPIFA1       5.49E-06      0.153040902   1.29842003
  DYDC2        5.56E-06      0.154968104   1.290632913
  SAA1         5.82E-06      0.162381965   1.167439591
  SYT8         5.84E-06      0.162863691   1.054481629
  C4orf22      5.89E-06      0.164313163   1.248512247
  COL17A1      6.60E-06      0.184046213   1.676913349
  BAAT         7.02E-06      0.19588472    1.125812636
  PRSS12       7.08E-06      0.19749345    1.041357198
  ACTG2        7.19E-06      0.200389326   1.098429643
  FHOD3        7.24E-06      0.202037794   1.007947849
  AKAP14       7.70E-06      0.214805786   1.155126263
  TSGA10       8.25E-06      0.23012123    1.084478327
  MXRA5        9.00E-06      0.251085283   1.072081569
  CHIT1        9.20E-06      0.256665502   1.116001213
  HHLA2        9.93E-06      0.276806417   1.243490407
  VWA3B        1.09E-05      0.304184254   1.013600302
  FAM216B      1.22E-05      0.339444516   1.003245966
  ZMYND10      1.25E-05      0.349552078   1.06922834
  ATP12A       1.26E-05      0.352113661   1.241793927
  CDHR3        1.31E-05      0.366149094   1.003213287
  C1orf87      1.33E-05      0.370438911   1.240688082
  FCRL5        1.46E-05      0.407936307   1.074522645
  IQUB         1.55E-05      0.432685114   1.273083757
  DLEC1        1.56E-05      0.435688123   1.127617749
  TP63         1.79E-05      0.498074147   1.022168715
  DNER         1.87E-05      0.521842029   1.006616734
  TDO2         1.92E-05      0.536740731   1.017985205
  CCDC81       1.96E-05      0.547864087   1.111704424
  DTHD1        2.21E-05      0.616533406   1.220070607
  CCNA1        2.22E-05      0.618380293   1.109596078
  DNAH6        2.50E-05      0.696039249   1.205496793
  CCDC39       2.73E-05      0.762305285   1.064688193
  SIX1         2.80E-05      0.781215901   1.166844918
  TMEM232      2.92E-05      0.815239855   1.27748821
  DSG3         2.98E-05      0.830395002   1.004793382
  UGT1A6       3.08E-05      0.857680858   1.080278111
  DNAH3        3.37E-05      0.940459718   1.020961433
  AK7          3.47E-05      0.967454427   1.025283586
  CLIC6        3.98E-05      1             1.050256203
  SERPINB4     4.48E-05      1             1.286082732
  SPATA4       5.09E-05      1             1.054065177
  DNAH7        5.29E-05      1             1.07821031
  DNAH5        5.93E-05      1             1.025356953
  CCDC78       6.17E-05      1             1.001758647
  CAPN13       6.26E-05      1             1.075410711
  DNAI1        7.23E-05      1             1.169928958
  RIBC2        7.97E-05      1             1.006702152
  KLK12        8.41E-05      1             1.242575651
  CRLF1        8.88E-05      1             1.150088178
  SRD5A2       9.56E-05      1             1.075894376
  CLDN8        9.74E-05      1             1.30318712
  C10orf107    0.000109055   1             1.060098777
  STOX1        0.000109344   1             1.109895823
  C10orf81     0.000118127   1             1.119302483
  DDX3Y        0.000140361   1             1.049553425
  FAM183A      0.000153129   1             1.040469983
  CILP         0.000162266   1             1.173032082
  RSPH4A       0.000198839   1             1.091928915
  USP9Y        0.000203297   1             1.007151508
  EYA1         0.000317943   1             1.10128004
  MS4A8        0.00032339    1             1.005164192
  PTPRT        0.000360859   1             1.169300297
  GSTA5        0.000373902   1             1.000889231
  FHAD1        0.000393343   1             1.047998957
  IGFL2        0.000465987   1             1.312853186
  RHOV         0.000475109   1             1.033831468
  LDLRAD1      0.00055986    1             1.029189153
  PLA2G2A      0.000583188   1             1.096318802
  DNAAF1       0.000908779   1             1.062363628
  FAM92B       0.001034847   1             1.00072388
  GSTA2        0.001066812   1             1.005385962
  SPATS1       0.001099321   1             1.031573291
  MMP11        0.00110875    1             1.016851831
  CWH43        0.001450876   1             1.036477759
  TNS4         0.001582539   1             1.171200138
  PLA2G1B      1.44E-14      4.00E-10      −2.106784443
  AGER         8.34E-14      2.33E-09      −2.062573006
  CA4          4.34E-13      1.21E-08      −2.088124716
  SLC6A4       3.08E-12      8.60E-08      −2.237860051
  STX11        6.55E-12      1.83E-07      −1.325682912
  HSD17B6      8.40E-12      2.34E-07      −1.514855943
  CPB2         1.25E-11      3.47E-07      −1.76408969
  CLDN18       1.65E-11      4.59E-07      −1.520279583
  CRTAC1       3.07E-11      8.55E-07      −1.598044156
  GKN2         4.35E-11      1.21E-06      −1.339491525
  PLLP         5.22E-11      1.46E-06      −1.354622717
  FAM107A      5.54E-11      1.55E-06      −1.504206175
  PEBP4        6.23E-11      1.74E-06      −1.712436843
  IL1RL1       7.30E-11      2.04E-06      −1.393300726
  IL6          1.78E-10      4.97E-06      −2.045946662
  LRRN4        2.55E-10      7.11E-06      −1.300700327
  FCN3         2.76E-10      7.69E-06      −2.097486722
  RND1         2.79E-10      7.79E-06      −1.466163154
  AGTR2        4.24E-10      1.18E-05      −1.676540353
  STC1         5.83E-10      1.63E-05      −1.497051803
  SFTA2        5.83E-10      1.63E-05      −1.149823392
  MS4A15       6.77E-10      1.89E-05      −1.392910619
  HHIP         8.55E-10      2.39E-05      −1.641952122
  BTNL9        9.30E-10      2.59E-05      −1.479401795
  GPM6A        1.25E-09      3.48E-05      −1.401440693
  SLC26A9      1.31E-09      3.64E-05      −1.213384003
  HYAL1        1.34E-09      3.74E-05      −1.049135629
  NECAB1       1.65E-09      4.61E-05      −1.653062787
  SPRY4        2.34E-09      6.53E-05      −1.063958117
  RTKN2        3.17E-09      8.84E-05      −1.844810146
  CACNA2D2     3.17E-09      8.84E-05      −1.325524239
  HBEGF        3.37E-09      9.39E-05      −1.013418905
  CSF3R        3.44E-09      9.61E-05      −1.248564827
  ANKRD1       3.84E-09      0.000107106   −1.41285721
  VIPR1        4.21E-09      0.000117331   −1.559310652
  TMEM100      4.69E-09      0.000130713   −1.694707846
  CA2          5.96E-09      0.000166087   −1.028516653
  RXFP1        6.38E-09      0.000177931   −1.311761392
  MT1M         6.77E-09      0.000188683   −1.747649733
  SLC6A14      7.90E-09      0.000220316   −1.089465157
  CXCL2        1.19E-08      0.000330772   −1.004769994
  ADRB1        1.35E-08      0.000375261   −1.139606331
  PIGA         1.35E-08      0.000376122   −1.217675912
  LRRC32       1.78E-08      0.000497564   −1.128069969
  TNNC1        2.31E-08      0.000643874   −1.27225718
  ANXA3        2.37E-08      0.00066157    −1.058524507
  ZNF385B      3.25E-08      0.000907556   −1.229033975
  PROK2        3.61E-08      0.00100569    −1.514684378
  CHI3L2       4.18E-08      0.001166833   −1.427095228
  SLC19A3      4.57E-08      0.001274104   −1.10459671
  S100A12      4.62E-08      0.00128834    −2.252364042
  GPIHBP1      5.50E-08      0.001534937   −1.187373977
  LAMP3        5.76E-08      0.001606384   −1.159421533
  DAPK2        7.35E-08      0.002049604   −1.02316703
  ACADL        7.61E-08      0.002122618   −1.119836013
  MME          7.67E-08      0.002138363   −1.092020465
  STXBP6       8.62E-08      0.002403444   −1.092919132
  NDRG4        9.12E-08      0.002542679   −1.016978682
  EPB41L5      1.00E-07      0.002788995   −1.009261675
  CSF3         1.02E-07      0.002831121   −1.251734223
  CDH13        1.33E-07      0.003708031   −1.007819606
  GRIA1        1.34E-07      0.003740217   −1.377236278
  S1PR1        1.39E-07      0.0038712     −1.029547489
  MGAM         1.41E-07      0.003940929   −1.466668873
  ABCA3        1.46E-07      0.004074518   −1.199031193
  EDNRB        1.84E-07      0.005127183   −1.128719906
  MAFF         2.20E-07      0.006122403   −1.097428593
  SLC39A8      2.56E-07      0.007141459   −1.216623582
  KLF4         3.11E-07      0.008664018   −1.041025187
  SDR16C5      3.82E-07      0.010656914   −1.275861012
  CCK          4.33E-07      0.012065446   −1.159781479
  ITLN2        4.63E-07      0.012905847   −1.722536404
  IL1R2        4.63E-07      0.012905847   −1.225516832
  SERTM1       4.85E-07      0.013532256   −1.235269195
  MATN3        5.39E-07      0.015037563   −1.013765474
  SLCO4A1      6.21E-07      0.017322509   −1.218439326
  FGG          6.48E-07      0.018079474   −1.260330186
  HECW2        7.80E-07      0.021754525   −1.113597001
  APOH         8.86E-07      0.024696133   −1.081456999
  SUSD2        8.96E-07      0.02498895    −1.008091337
  NAMPT        1.15E-06      0.032162761   −1.047173312
  SLC46A2      1.73E-06      0.048361585   −1.026945366
  SOSTDC1      1.84E-06      0.051255152   −1.228238809
  SLC5A9       2.34E-06      0.065287501   −1.228911687
  CCDC85A      2.39E-06      0.066612171   −1.067734881
  IL18RAP      2.44E-06      0.068162213   −1.202066709
  ERRFI1       2.88E-06      0.08029286    −1.09242787
  ORM1         3.26E-06      0.090825371   −1.085120865
  CXCL3        3.26E-06      0.091010933   −1.001088364
  SPOCK2       3.43E-06      0.095778504   −1.023342385
  S100A3       3.49E-06      0.097452831   −1.061209678
  CEBPD        3.87E-06      0.107980901   −1.093847526
  S100A8       4.39E-06      0.122472366   −1.339030199
  SLCO1A2      5.14E-06      0.143355387   −1.086207968
  ESM1         6.05E-06      0.16871941    −1.078977525
  CSRNP1       6.49E-06      0.180900922   −1.136678398
  FGFBP2       8.96E-06      0.249934931   −1.148678049
  BDNF         8.98E-06      0.250476093   −1.076553749
  ZFP36        1.01E-05      0.281124207   −1.027441113
  DLL4         1.05E-05      0.292138522   −1.063256088
  DEFA1B       1.16E-05      0.322399438   −1.011654806
  VNN2         1.17E-05      0.325560059   −1.015560522
  PTX3         1.34E-05      0.374984707   −1.338994441
  F11          1.52E-05      0.423768653   −1.184438918
  HTR3C        1.66E-05      0.464166403   −1.178516229
  HMGCS2       1.70E-05      0.47451476    −1.14093025
  ARC          2.03E-05      0.567374491   −1.211855264
  ORM2         2.07E-05      0.577788023   −1.019830926
  FPR2         2.11E-05      0.587693475   −1.029517016
  GPX3         2.24E-05      0.623819328   −1.009177645
  XIST         2.28E-05      0.635537729   −1.103246381
  MT1E         2.36E-05      0.658399738   −1.006714478
  NR4A2        2.54E-05      0.706999207   −1.027905066
  RS1          2.64E-05      0.734963593   −1.020756087
  FOSB         3.08E-05      0.857680858   −1.206609882
  RBP2         3.38E-05      0.941426241   −1.007947503
  KLRF1        3.44E-05      0.96012864    −1.045789521
  IL13         4.17E-05      1             −1.023145887
  S100A9       8.75E-05      1             −1.045992124
  ADM          0.00020169    1             −1.022596555

###### 

Pathway and process enrichment analysis of those functional coexpression modules in IPF.

  Modules          GO                        Category                                                                    Description                                Count   \%       Log10(P)   Log10(q)
  ---------------- ------------------------- --------------------------------------------------------------------------- ------------------------------------------ ------- -------- ---------- ----------
  Black module     GO: 0062023               GO Cellular Components                                                      Collagen-containing extracellular matrix   55      16.57    −42.21     −37.86
  GO: 0044420      GO Cellular Components    Extracellular matrix component                                              14                                         4.22    −14.54   −10.96     
  GO: 0005539      GO Molecular Functions    Glycosaminoglycan binding                                                   23                                         6.93    −13.09   −9.58      
  GO: 0005509      GO Molecular Functions    Calcium ion binding                                                         39                                         11.75   −12.87   −9.47      
  GO: 0001501      GO Biological Processes   Skeletal system development                                                 33                                         9.94    −12.8    −9.45      
  GO: 0005178      GO Molecular Functions    Integrin binding                                                            17                                         5.12    −11.75   −8.43      
  GO: 0001944      GO Biological Processes   Vasculature development                                                     38                                         11.45   −10.59   −7.37      
  GO: 0005604      GO Cellular Components    Basement membrane                                                           13                                         3.92    −9.38    −6.27      
  GO: 0001503      GO Biological Processes   Ossification                                                                24                                         7.23    −9.13    −6.1       
  GO: 0060485      GO Biological Processes   Mesenchyme development                                                      20                                         6.02    −8.9     −5.9       
  Yellow module    GO: 0097529               GO Biological Processes                                                     Myeloid leukocyte migration                23      6.04     −12.85     −8.61
  GO: 0002366      GO Biological Processes   Leukocyte activation involved in immune response                            41                                         10.76   −12.25   −8.42      
  GO: 0006954      GO Biological Processes   Inflammatory response                                                       42                                         11.02   −11.26   −7.86      
  GO: 0098542      GO Biological Processes   Defense response to other organism                                          30                                         7.87    −8.34    −5.44      
  GO: 0010942      GO Biological Processes   Positive regulation of cell death                                           34                                         8.92    −8.28    −5.41      
  GO: 0042581      GO Cellular Components    Specific granule                                                            16                                         4.2     −8.25    −5.41      
  GO: 0043410      GO Biological Processes   Positive regulation of MAPK cascade                                         30                                         7.87    −8.09    −5.26      
  hsa05206         KEGG Pathway              MicroRNAs in cancer                                                         21                                         5.51    −7.84    −5.04      
  GO: 1901342      GO Biological Processes   Regulation of vasculature development                                       25                                         6.56    −7.67    −4.89      
  GO: 0006953      GO Biological Processes   Acute-phase response                                                        9                                          2.36    −7.35    −4.62      
  Blue module      GO: 0005929               GO Cellular Components                                                      Cilium                                     67      8.08     −16.89     −12.53
  GO: 0031514      GO Cellular Components    Motile cilium                                                               26                                         3.14    −9.31    −5.55      
  GO: 0016266      GO Biological Processes   O-glycan processing                                                         11                                         1.33    −5.19    −1.98      
  GO: 0045503      GO Molecular Functions    Dynein light chain binding                                                  7                                          0.84    −4.81    −1.76      
  GO: 0004497      GO Molecular Functions    Monooxygenase activity                                                      13                                         1.57    −4.47    −1.47      
  GO: 1904158      GO Biological Processes   Axonemal central apparatus assembly                                         3                                          0.36    −4.39    −1.43      
  GO: 0023024      GO Molecular Functions    MHC class I protein complex binding                                         3                                          0.36    −4.39    −1.43      
  GO: 0002223      GO Biological Processes   Stimulatory C-type lectin receptor signaling pathway                        10                                         1.21    −4.15    −1.26      
  GO: 0001889      GO Biological Processes   Liver development                                                           15                                         1.81    −4.12    −1.24      
  GO: 0045177      GO Cellular Components    Apical part of cell                                                         28                                         3.38    −3.95    −1.14      
  Mengeta module   GO: 0000280               GO Biological Processes                                                     Nuclear division                           54      24       −45.01     −40.65
  GO: 0071103      GO Biological Processes   DNA conformation change                                                     46                                         20.44   −42.92   −39.27     
  GO: 0044770      GO Biological Processes   Cell cycle phase transition                                                 47                                         20.89   −30.44   −27.28     
  GO: 0006260      GO Biological Processes   DNA replication                                                             36                                         16      −30.31   −27.19     
  GO: 0005819      GO Cellular Components    Spindle                                                                     35                                         15.56   −25.8    −22.84     
  GO: 1903046      GO Biological Processes   Meiotic cell cycle process                                                  26                                         11.56   −22.27   −19.43     
  GO: 0006281      GO Biological Processes   DNA repair                                                                  36                                         16      −19.92   −17.18     
  GO: 0034508      GO Biological Processes   Centromere complex assembly                                                 15                                         6.67    −17.6    −14.98     
  GO: 0005815      GO Cellular Components    Microtubule organizing center                                               36                                         16      −15.54   −13.01     
  GO: 0030496      GO Cellular Components    Midbody                                                                     18                                         8       −13.36   −10.96     
  Pink module      GO: 0042110               GO Biological Processes                                                     T cell activation                          56      19.24    −39.21     −34.85
  GO: 0098552      GO Cellular Components    Side of membrane                                                            49                                         16.84   −27.35   −23.77     
  GO: 0050852      GO Biological Processes   T cell receptor signaling pathway                                           27                                         9.28    −23.27   −20.03     
  GO: 0001816      GO Biological Processes   Cytokine production                                                         50                                         17.18   −23.19   −19.98     
  GO: 0045058      GO Biological Processes   T cell selection                                                            16                                         5.5     −18.68   −15.81     
  GO: 0019221      GO Biological Processes   Cytokine-mediated signaling pathway                                         43                                         14.78   −17.21   −14.39     
  hsa04660         KEGG Pathway              T cell receptor signaling pathway                                           18                                         6.19    −15.43   −12.71     
  GO: 0042101      GO Cellular Components    T cell receptor complex                                                     10                                         3.44    −15      −12.29     
  GO: 0046631      GO Biological Processes   alpha-beta T cell activation                                                19                                         6.53    −14.5    −11.84     
  GO: 0031349      GO Biological Processes   Positive regulation of defense response                                     29                                         9.97    −13.11   −10.51     
                   GO: 0001568               GO Biological Processes                                                     Blood vessel development                   66      10.48    −17.01     −12.65
  Brown module     GO: 0034330               GO Biological Processes                                                     Cell junction organization                 34      5.4      −12.64     −8.98
  GO: 0016126      GO Biological Processes   Sterol biosynthetic process                                                 18                                         2.86    −11.61   −8.1       
  GO: 0070848      GO Biological Processes   Response to growth factor                                                   53                                         8.41    −10.72   −7.26      
  GO: 0030155      GO Biological Processes   Regulation of cell adhesion                                                 48                                         7.62    −9.5     −6.25      
  GO: 0003018      GO Biological Processes   Vascular process in circulatory system                                      21                                         3.33    −8.83    −5.7       
  GO: 0005911      GO Cellular Components    Cell-cell junction                                                          34                                         5.4     −7.63    −4.72      
  GO: 0070372      GO Biological Processes   regulation of ERK1 and ERK2 cascade                                         28                                         4.44    −7.38    −4.5       
  GO: 0008285      GO Biological Processes   Negative regulation of cell proliferation                                   46                                         7.3     −6.92    −4.18      
  GO: 0007610      GO Biological Processes   Behavior                                                                    38                                         6.03    −6.59    −3.93      
  GO: 0001568      GO Biological Processes   Blood vessel development                                                    66                                         10.48   −17.01   −12.65     
  Red module       hsa04740                  KEGG Pathway                                                                Olfactory transduction                     108     6.76     −34.96     −30.6
  GO: 0031424      GO Biological Processes   Keratinization                                                              58                                         3.63    −19.08   −15.72     
  GO: 0030594      GO Molecular Functions    Neurotransmitter receptor activity                                          26                                         1.63    −7.43    −4.33      
  GO: 0005179      GO Molecular Functions    Hormone activity                                                            26                                         1.63    −7.12    −4.04      
  GO: 0005261      GO Molecular Functions    Cation channel activity                                                     48                                         3       −7.04    −3.98      
  hsa04080         KEGG Pathway              Neuroactive ligand-receptor interaction                                     41                                         2.57    −5.92    −2.96      
  GO: 0007188      GO Biological Processes   Adenylate cyclase-modulating G protein-coupled receptor signaling pathway   34                                         2.13    −5.38    −2.5       
  GO: 0009566      GO Biological Processes   Fertilization                                                               29                                         1.81    −5.22    −2.35      
  GO: 0005549      GO Molecular Functions    Odorant binding                                                             19                                         1.19    −4.83    −2.03      
  GO: 0007210      GO Biological Processes   Serotonin receptor signaling pathway                                        11                                         0.69    −4.51    −1.82      

###### 

Sample clustering to detect outliers. The red line is used to distinguish the outlier samples. The threshold is set as 55, and three outlier samples (GSM806290, GSM806408, GSM806411) were removed from the sample cohort.

###### 

The visualization of the coexpression networks. Nodes represent genes, and node color is the same as the module color node.
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![The top 25 upregulated genes and top 25 down-regulated genes in idiopathic pulmonary fibrosis (IPF). Each column represents one dataset, and each row represents one gene. The numbers in each rectangle show the logarithmic fold-change of genes in each dataset. Red indicates increased gene expression, and green indicates decreased gene expression.](medscimonit-25-4285-g001){#f1-medscimonit-25-4285}

![Plots in the weighted gene coexpression network analysis (WGCNA) using gene expression data from 119 patients with idiopathic pulmonary fibrosis (IPF) and 50 controls from GSE32537 datasets. (**A**) Network topology of different soft-thresholding powers. The left panel shows the influence of the soft-threshold power on the scale-free topology fit index. The right panel shows the influence of the soft-threshold power on the mean connectivity. (**B**) Cluster dendrogram of coexpression genes and functional modules in IPF. Eight coexpression modules were constructed and are shown in different colors. (**C**) A heatmap plot shows the gene network. Different colors of the horizontal axis and the vertical axis represent different modules. The light color indicates lower overlap, and the dark red indicates higher overlap.](medscimonit-25-4285-g002){#f2-medscimonit-25-4285}

![Heatmap of the correlation between module eigengenes and clinical traits of idiopathic pulmonary fibrosis (IPF). The table is color-coded by correlation according to the color legend. Each cell contains the corresponding correlation and p-value.](medscimonit-25-4285-g003){#f3-medscimonit-25-4285}

![Heatmap plot of the adjacencies of modules. The change of color from blue (0) to red (1) in the heatmap represents the degree of connectivity of different modules from weak to strong.](medscimonit-25-4285-g004){#f4-medscimonit-25-4285}

![A scatterplot of gene significance for idiopathic pulmonary fibrosis (IPF) status versus module membership in the black module and yellow module. The correlation coefficient and the corresponding P-values are shown at the top of the scatterplot.](medscimonit-25-4285-g005){#f5-medscimonit-25-4285}

![Network diagram of the top 30 genes in idiopathic pulmonary fibrosis (IPF). (**A**) The network of top 30 genes in the dark magenta module. (**B**) The network of top 30 genes in the yellow module. Node size: larger size indicates a higher degree of connectivity, and a smaller size indicates a lower degree of connectivity. Node color: Red indicates an upregulated gene. Green indicates a down-regulated gene.](medscimonit-25-4285-g006){#f6-medscimonit-25-4285}

![The overlap of differentially expressed genes (DEGs) and hub genes shown as a Venn diagram. (**A**) Identification of common genes between differentially expressed genes (DEGs) and the black module overlapping them. The two hub genes in the black module were also DEGs obtained from the robust rank aggregation (RRA) analysis. (**B**) Identification of common genes between DEGs and the yellow module overlapping them. The two hub genes in the yellow module were also DEGs obtained from the RRA analysis.](medscimonit-25-4285-g007){#f7-medscimonit-25-4285}

![Functional and pathway enrichment analysis. (**A**) Functional and pathway enrichment analysis of the black module. (**B**) Functional and pathway enrichment analysis of the yellow module. Heatmap of top 20 clusters, colored by P-values. Each bar represents a cluster. The darker the color of the bar is, the smaller the P-value.](medscimonit-25-4285-g008){#f8-medscimonit-25-4285}

###### 

Results of CMap analysis.

  cmap name        Mean     n   p
  ---------------- -------- --- ---------
  Pregnenolone     −0.524   4   0.00022
  Lycorine         −0.425   5   0.00555
  Chloropyrazine   −0.347   4   0.00573
  Securinine       −0.661   4   0.01215
  Rotenone         −0.477   4   0.02043
  Indoprofen       −0.326   4   0.02449
  Megestrol        −0.348   4   0.03463
  Terazosin        −0.328   4   0.03766

The compounds tested in at least four experiments were ranked according to p value.

###### 

Summary of those 6 genome-wide gene expression datasets involving IPF patients.

  Dataset ID   GSE number   Samples                           IPF age(years)   IPF Sex (M/F)   Source types   Platform   Authors
  ------------ ------------ --------------------------------- ---------------- --------------- -------------- ---------- -------------------------------------------
  1            GSE10667     23 IPF samples and 15 controls    61.71±5.51       19/4            Lung tissues   GPL4133    Konishi K, Richards TJ, Kaminski N
  2            GSE15197     8 IPF samples and 13 controls     60±5             5/3             Lung tissues   GPL6480    Rajkumar R, Konishi K, Richards TJ et al.
  3            GSE21369     11 IPF samples and 6 controls     58.09±9.48       8/3             Lung tissue    GPL570     Cho JH, Gelinas R, Wang K et al.
  4            GSE24206     8 IPF samples and 6 controls      61.25±6.32       7/1             Lung tissue    GPL570     Meltzer EB, Barry WT, D'Amico TA et al.
  5            GSE32537     119 IPF samples and 50 controls   62.55±8.75       77/42           Lung tissue    GPL6244    Yang IV, Coldren CD, Leach SM et al.
  6            GSE110147    22 IPF samples and 11 controls    62±6             17/5            Lung tissue    GPL6244    Cecchini MJ, Hosein K, Howlett CJ et al.
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